Regulatory News
Tuesday, March 29, 2016
BRIEF-Biolinerx reports successful top-line phase 2 trial results
* Successful results in phase 2 trial for AML data identify
a potential biomarker for future selection of BL-8040-responsive
AML patients
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment